2017 Cocaine Dependence Pipeline Update - ResearchAndMarkets.com

DUBLIN--()--The "Cocaine Dependence Pipeline Highlights - 2017 Update" drug pipelines has been added to ResearchAndMarkets.com's offering.

Cocaine Dependence Pipeline Highlights - 2017 Update provides most up-to-date information on key pipeline products in the global Cocaine Dependence market.

It covers emerging therapies for Cocaine Dependence in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Cocaine Dependence pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Cocaine Dependence pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Cocaine Dependence pipeline products by the company.

Short-term Launch Highlights:

Find out which Cocaine Dependence pipeline products will be launched in the US and Ex-US till 2020.

Key Topics Covered:

1. Cocaine Dependence Pipeline by Stages

2. Cocaine Dependence Pipeline by Drug Class

3. Cocaine Dependence Pipeline by Company

4. Cocaine Dependence Phase 3 Clinical Trial Insights

5. Cocaine Dependence Phase 2 Clinical Trial Insights

6. Cocaine Dependence Phase 1 Clinical Trial Insights

7. Cocaine Dependence Preclinical Research Insights

8. Cocaine Dependence Discovery Stage Insights

9. Appendix

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/sqsb75/2017_cocaine?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Addiction Disorders Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Addiction Disorders Drugs